1. Market Research
  2. > Healthcare
  3. > Pathology Market Trends
NPS+ Haemophilia A (US) 2017

NPS+ Haemophilia A (US) 2017

  • August 2017
  • ID: 5175278
  • Format: PDF
  • Firstword Pharma


Table of Contents

Major brands are stuck in a rut with US doctors

Haemophilia A drugs seem to be stuck in a rut with US doctors. The majority of haematologists surveyed for this report say they’re satisfied with available brands, and their candid feedback is mostly positive. So why doesn’t that come through in their satisfaction ratings? Only two of the brands we asked them about eked out positive satisfaction scores, while scores for the other nine are slightly to solidly negative.

Find out how doctors rated your brand, get insight into why, and learn what you can do to boost your satisfaction score in FirstView’s NPS+ Haemophilia A 2017 (US).

Building on the respected net promoter score (NPS), the report compares nine major haemophilia A drugs, and shows you:

How loyal doctors are to your brand.
Which promotional messages resonate best.
What doctors really think of your brand, revealed in a unique “Brand DNA” section.

All with easy-to-use KPIs that highlight ways you can improve brand health.

Top Takeaways

In a rut: While doctors are moderately satisfied with the surveyed brands, and have mostly positive things to say about most of them, NPS and loyalty scores are low across the board.
Barely eking out a win: The top 2 brands are the only ones to earn positive NPS scores, and even they’re hovering just above 0.
Whatever works: Scarcely more than 10% of doctors prescribe any one brand exclusively, and Promoters of one brand prescribe more than 6 others on average.
Pulling farther ahead: The leading brand could increase its lead, and boost its market share by up to more than 400%, by winning over Detractors.
Go-to alternative: Up to 93% of Promoters of 7 of the surveyed brands also recommend a competing brand that, according to one respondent, more patients are requesting.
Cost is a top concern for one brand: Cost effectiveness is a top-5 promotional message for only 4 of the surveyed brands, but for one of them it’s the biggest driver of recommendations.

Insight into 11 Major Haemophilia A Treatments

Advate (rurioctocog alfa; Shire)
Adynovate (rurioctocog alfa pegol; Shire)
Eloctate (efmoroctocog alfa; Bioverativ/Biogen)
Feiba (Anti-Inhibitor Coagulant Complex; Shire)
Helixate FS (octocog alfa; CSL Behring)
Humate-P (Antihemophilic Factor/von Willebrand Factor Complex [human]; CSL Behring)
Kogenate FS (octocog alfa; Bayer)
Kovaltry (octocog alfa; Bayer)
NovoEight (turoctocog alfa; Novo Nordisk)
Nuwiq (simoctocog alfa; Octapharma)
Xyntha (moroctocog alfa; Pfizer)

A Report Based on Expert Knowledge

We surveyed 100 US-based haematologists chosen from the largest community of validated physicians in the world. The same community that pharma market researchers trust for reliable, fast intelligence.

We conducted the survey between August 1st and 22nd, 2017.

Explore Important Brand Loyalty Issues

NPS+ Haemophilia A 2017 (US) explores key issues affecting brand loyalty for drug manufacturers. You’ll learn:

How satisfied doctors are with available treatments.
How loyal doctors are to your brand.
How many other brands your Promoters recommend.
Which other brands your Promoters and Detractors recommend.
How much market share your brand has among Promoters and Detractors.
How much market share you stand to gain by converting Detractors into Promoters.
Which messages Promoters, Passives and Detractors associate with your brand.
Your brand DNA: what doctors really think of your brand—in their own words.

What is Net Promoter® Score?

NPS is a customer loyalty metric developed by (and a registered trademark of) Fred Reichheld, Bain & Company, and Satmetrix. It was introduced by Reichheld in his 2003 Harvard Business Review article One Number You Need to Grow.

How does NPS work?

NPS measures overall brand satisfaction and loyalty by asking one simple question:
"How likely are you to recommend this brand to a colleague?"
Responses - given on a scale of 0 (not at all likely) to 10 (extremely likely)—are used to classify respondents into 3 categories:

Detractors are those who answer 0 – 6.
Passives are those who answer 7 – 8.
Promoters are those who answer 9 - 10.

How is NPS calculated?

The percentage of detractors - the percentage of promoters = NPS.

For example, 25% Promoters, 55% Passives and 20% Detractors give you an NPS of +5.

NPS can range from -100 (everybody is a Detractor) to +100 (everybody is a Promoter). The higher the score the healthier the brand.

What is FirstView NPS+?

NPS+ turns your Net Promoter Score into actionable information by answering key questions about brand loyalty. 

Each NPS+ report examines doctors’ relationships with the brands used to treat a major disease area—measuring brand loyalty and showing you how it affects your market share. NPS+ also examines “brand DNA”, revealing in doctors’ own words what brands mean to them. 

Instead of one simple metric, NPS+ gives you a detailed picture of brand health that highlights areas for improvement, and helps you see exactly what steps you need to take next. 

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 150+ Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
  • Single User License — provides access to the report by one individual.
  • Department License — allows you to share the report with up to 5 users
  • Site License — allows the report to be shared amongst all employees in a defined country
  • Corporate License — allows for complete access, globally.

ReportLinker may already be registered as a supplier with your company. If you want to Order by PO, check with us first and we'll let you know if we are a registered supplier and what the vendor number is. Otherwise, we'll provide you with the necessary information to register ReportLinker as a vendor.

Ahmad helps you find the right report:

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

We were impressed with the support that ReportLinker’s research specialists’ team provided. The report we purchased was useful and provided exactly what we want.

Category Manager at

ReportLinker gave access to reliable and useful data while avoiding dispersing resources and spending too much time on unnecessary research.

Executive Director at
PwC Advisory

The customer service was fast, responsive, and 100% professional in all my dealings (...) If we have more research needs, I'll certainly prioritize working with ReportLinker!

Scott Griffith

Vice President Marketing at
Maurice Sporting Goods

The research specialist provided prompt, helpful instructions for accessing ReportLinker's product. He also followed up to make sure everything went smoothly and to ensure an easy transition to the next stage of my research

Jessica P Huffman

Research Associate at
American Transportation Research Institute

Excellent customer service. Very responsive and fast.

Director, Corporate Strategy at

I reached out to ReportLinker for a detailed market study on the Air Treatment industry. The quality of the report, the research specialist’s willingness to solve my queries exceeded my expectations. I would definitely recommend ReportLinker for in-depth industry information.

Mariana Mendoza

Global Platform Senior Manager at
Whirlpool Corporation

Thanks! I like what you've provided and will certainly come back if I need to do further research works.

Bee Hin Png

CEO at
LDR Pte Ltd

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

  • How we can help
    • I am not sure if the report I am interested in will fulfill my needs. Can you help me?
    • Yes, of course. You can call us at +33(0) 4 37 65 17 03 or drop us an email at researchadvisor@reportlinker.com to let us know more about your requirements.
    • We buy reports often - can ReportLinker get me any benefits?
    • Yes. Set up a call with a Senior Research Advisor to learn more - researchadvisor@reportlinker.com or +33(0) 4 37 65 17 03.
    • I have had negative experiences with market research reports before. How can you avoid this from happening again?
    • We advise all clients to read the TOC and Summary and list your questions so that we can get more insight for you before you make any purchase decision. A research advisor will accompany you so that you can compare samples and reports from different sources, and choose the study that is right for you.

  • Report Delivery
    • How and when I will receive my Report?
    • Most reports are delivered right away in a pdf format, while others are accessed via a secure link and access codes. Do note that sometimes reports are sent within a 12 hour period, depending on the time zones. However, you can contact us to escalate this. Should you need a hard copy, you can check if this option is offered for the particular report, and pay the related fees.
  • Payment conditions
    • What payment methods do you accept?
      1. Credit card : VISA, American Express, Mastercard, or
      2. You can download an invoice to pay by wire transfer, check, or via a Purchase Order from your company, or
      3. You can pay via a Check made out in US Dollars, Euros, or British Pounds for the full amount made payable to ReportLinker
    • What are ReportLinker’s Payment Terms?
    • All payments must normally be submitted within 30 days. However, you can let us know if you need extended time.
    • Are Taxes and duties included?
    • All companies based in France must pay a 20% tax per report. The same applies to all individuals based in the EU. All EU companies must supply their VAT number when purchasing to avoid this charge.
    • I’m not satisfied. Can I be refunded?
    • No. Once your order has been processed and the publisher has received a notification to send you the report, we cannot issue any refund or cancel any order. As these are not ‘traditional’ products that can be returned, reports that are dispatched are considered to be ‘consumed’.
  • User license
    • The license that you should acquire depends on the number of persons that need to access the report. This can range from Single User (only one person will have the right to read or access the report), or Department License (up to 5 persons), to Site License (a group of persons based in the same company location), or Corporate License (the entire company personnel based worldwide). However, as publishers have different terms and conditions, we can look into this for you.
Purchase Reports From Reputable Market Research Publishers

Hemoglobinopathies Treatment Market Research and Outlook, 2020- Trends, Growth Opportunities and Forecasts to 2028

  • $ 4880
  • February 2021
  • 110 pages

Hemoglobinopathies Treatment Market Report Overview Hemoglobinopathies Treatment market size outlook report provides comprehensive coverage of market landscape including strategic growth areas, unique ...

  • World
  • Blood Disease
  • Industry analysis
  • Health Provider Density


Reportlinker.com © Copyright 2021. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.

Make sure you don’t miss any news and follow us on